EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cold and hot fibrosis define clinically distinct cardiac pathologies

Shoval Miyara, Miri Adler, Kfir B Umansky, Daniel Häußler, Elad Bassat, Yalin Divinsky, Jacob Elkahal, David Kain, Daria Lendengolts, Ricardo O Ramirez Flores, Hanna Bueno-Levy, Ofra Golani und 21 weitere

Cell Systems · 2025-03 · 16 (3) · 101198

DOI: 10.1016/j.cels.2025.101198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Systems, 2025-03. Verfasst von Shoval Miyara und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Myocardial Infarction, Heart Failure. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, European Union's Research and Innovation, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis remains a major unmet medical need. Simplifying principles are needed to better understand fibrosis and to yield new therapeutic approaches. Fibrosis is driven by myofibroblasts that interact with macrophages. A mathematical cell-circuit model predicts two types of fibrosis: hot fibrosis driven by macrophages and myofibroblasts and cold fibrosis driven by myofibroblasts alone. Testing these concepts in cardiac fibrosis resulting from myocardial infarction (MI) and heart failure (HF), we revealed that acute MI leads to cold fibrosis whereas chronic injury (HF) leads to hot fibrosis. MI-driven cold fibrosis is conserved in pigs and humans. We computationally identified a vulnerability of cold fibrosis: the myofibroblast autocrine growth factor loop. Inhibiting this loop by targeting TIMP1 with neutralizing antibodies reduced myofibroblast proliferation and fibrosis post-MI in mice. Our study demonstrates the utility of the concepts of hot and cold fibrosis and the feasibility of a circuit-to-target approach to pinpoint a treatment strategy that reduces fibrosis. A record of this paper's transparent peer review process is included in the supplemental information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionHeart FailureFibrosisAnimalsHumansMiceMyofibroblastsSwineMacrophagesMyocardiumTissue Inhibitor of Metalloproteinase-1

Stichwörter der Autor:innen

TIMP1autocrine loopcold fibrosisfibrosisheart failurehot fibrosismacrophagemyocardial infarctionmyofibroblastregeneration

Substanzen

Tissue Inhibitor of Metalloproteinase-1

Autor:innen und Institutionen

  • Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Tananbaum Center for Theoretical and Analytical Human Biology, Yale University School of Medicine, New Haven, CT, USA.
  • TUM School of Medicine and Health, Institute of Experimental Oncology and Therapy Research, Technical University of Munich, Munich, Germany.
  • Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
  • Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany.
  • Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Förderung

  • Israel Science Foundation
  • European Union's Research and Innovation
  • German Research Foundation
  • European Research Council
  • Cancer Research UK

Zitieren

APA

Miyara, S., Adler, M., Umansky, K. B., Häußler, D., Bassat, E., Divinsky, Y., Elkahal, J., Kain, D., Lendengolts, D., Ramirez Flores, R. O., Bueno-Levy, H., Golani, O., Shalit, T., Gershovits, M., Weizman, E., Genzelinakh, A., Kimchi, D. M., Shakked, A., Zhang, L., …, & Tzahor, E. (2025). Cold and hot fibrosis define clinically distinct cardiac pathologies. Cell Systems, 16(3), 101198. https://doi.org/10.1016/j.cels.2025.101198

Vancouver

Miyara S, Adler M, Umansky KB, Häußler D, Bassat E, Divinsky Y, et al. Cold and hot fibrosis define clinically distinct cardiac pathologies. Cell Systems. 2025;16(3):101198. doi:10.1016/j.cels.2025.101198

BibTeX
@article{Miyara2025,
  author = {Miyara, Shoval and Adler, Miri and Umansky, Kfir B and Häußler, Daniel and Bassat, Elad and Divinsky, Yalin and Elkahal, Jacob and Kain, David and Lendengolts, Daria and Ramirez Flores, Ricardo O and Bueno-Levy, Hanna and Golani, Ofra and Shalit, Tali and Gershovits, Michael and Weizman, Eviatar and Genzelinakh, Alexander and Kimchi, Danielle M and Shakked, Avraham and Zhang, Lingling and Wang, Jingkui and Baehr, Andrea and Petrover, Zachary and Sarig, Rachel and Dorn, Tatjana and Moretti, Alessandra and Saez-Rodriguez, Julio and Kupatt, Christian and Tanaka, Elly M and Medzhitov, Ruslan and Krüger, Achim and Mayo, Avi and Alon, Uri and Tzahor, Eldad},
  title = {Cold and hot fibrosis define clinically distinct cardiac pathologies},
  journal = {Cell Systems},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {101198},
  doi = {10.1016/j.cels.2025.101198}
}
Kostenlos starten →